Home/Filings/4/0001104659-25-078783
4//SEC Filing

Waheed Nadia 4

Accession 0001104659-25-078783

CIK 0001393434other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 5:51 PM ET

Size

7.6 KB

Accession

0001104659-25-078783

Insider Transaction Report

Form 4
Period: 2025-08-12
Waheed Nadia
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2025-08-12+40,363247,168 total
  • Award

    Stock Option (Right to Buy)

    2025-08-12+122,923122,923 total
    Exercise: $12.48Exp: 2035-08-11Common Stock (122,923 underlying)
Footnotes (2)
  • [F1]On August 12, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on February 11, 2026.
  • [F2]7/48 of the shares underlying the option vest on September 11, 2025, and 1/48 of the shares underlying the option vest monthly thereafter through February 11, 2029.

Issuer

OCULAR THERAPEUTIX, INC

CIK 0001393434

Entity typeother

Related Parties

1
  • filerCIK 0002023884

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:51 PM ET
Size
7.6 KB